The effects of bisphosphonate on differentiation and distribution of osteoclast using zebrafish as an in vivo animal model
碩士 === 國立臺灣大學 === 臨床牙醫學研究所 === 102 === Objectives: Bisphosphonates began to be prescribed in the 1980s, often used in osteoporosis, bone metastasis of malignant tumors, multiple myeloma. Over 200 million oral and nearly three million intravenous prescriptions were made until 2006. However, 36 cases...
Main Authors: | Chia-Yuan Hu, 胡家源 |
---|---|
Other Authors: | Jou-Song Wang |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/59790776556097508000 |
Similar Items
-
The effects of a bisphosphonate on angiogenesis using zebrafish as an in vivo animal model
by: Tan-Ching Hsu, et al.
Published: (2015) -
Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model
by: Tingsheng Yu, et al.
Published: (2016-02-01) -
Current Topics in Pharmacological Research on Bone Metabolism: Inhibitory Effects of Bisphosphonates on the Differentiation and Activity of Osteoclasts
by: Keiko Suzuki, et al.
Published: (2006-01-01) -
The studies of radiofrequency on the osteoclasts/osteoblasts endocytosed magnetite-bisphosphonates nanoparticles
by: Chin-Chieh Lan, et al.
Published: (2010) -
Using TRAP staining method to reveal the effects of bisphosphonate on osteoclast during bone regeneration
by: Han-Wei Wang, et al.
Published: (2013)